Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02944929
Other study ID # P150907
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date January 1, 2018
Est. completion date January 3, 2021

Study information

Verified date March 2020
Source Assistance Publique - Hôpitaux de Paris
Contact Nicolas Roche, MD
Phone + 33(1) 47 10 54 09
Email roche.nicolas@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The addition of a self-rehabilitation program to repeated Botulinum Toxin Injections (BTI) and usual physiotherapy should increase the proportion of patients who attain their Primary Treatment Goal (impairments and function) more than usual care (involving repeated Botulinum Toxin Injections and conventional physiotherapy), in post stroke out-patients with spasticity.


Description:

Stroke affects 150 000 persons in France each year. Most patients have activity limitations because of the resulting motor deficit and spasticity. Autonomy in activities of daily living is reduced.

The principal treatment for focal spasticity is currently intramuscular botulinum toxin injection (BTI).

BTI is classically combined with only 2 to 3 sessions of out-patient physiotherapy per week. This is mainly because of a lack of out-patient therapists. However, this amount of therapy is insufficient and does not follow current literature which shows that the intensity of physiotherapy affects the recovery of impairment and activity. This gap in our health system could be filled by a self-rehabilitation program in addition to physiotherapy.

Recent studies have shown that self-rehabilitation following BTI could significantly improve activity limitation (Roche et al, 2014 ; Sun et al 2010).

The addition of a self-rehabilitation program to BTI and usual out-patient physiotherapy could thus increase the effects of BTI on impairment and activity limitation in patients with spastic hemiparesis following stroke.


Recruitment information / eligibility

Status Recruiting
Enrollment 220
Est. completion date January 3, 2021
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

1. Males and females aged between 18 to 75 years.

2. Adult patient under guardianship with consent obtained and the legal guardian's authorisation obtained.

3. Single stroke having occurred more than 6 months before (previous TIA is accepted).

4. Capable of understanding instructions and participating in the definition of a therapeutic goal (Boston Diagnostic Aphasia Examination (BDAE) < 3).

5. Having previously undergone BTI. The last injection must have been performed at least 4 months prior to inclusion.

6. Affiliation to the French social security regime or a similar regime.

7. Patient (or the legal guardian if under guardian adult patient) has signed the informed consent form.

Exclusion Criteria:

1. Patients who are unwilling to participate in the study. For the one under guardianship, the refusal of the patient will be the final decision even if the guardian is willing to participate.

2. Subjects who are unlikely to adhere to the study an/or poor adherence anticipated by the investigator.

3. Un-controlled progressive pathology.

4. Osteoarticular lesion which contraindicates part of the rehabilitation involved in the study.

5. Patients with other interventions planned prior to the end of the study period (orthosis, surgery etc.).

6. Surgery to the treated limb less than 6 months previously.

7. Pregnant woman.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Self-rehabilitation program
The self-rehabilitation program will be based on muscle stretching, strengthening and task oriented exercises. For each patient, two exercises will be selected by the therapist for each of these 3 domains (total of 6 exercises) from a list of 50 exercises.

Locations

Country Name City State
France Hôpital Raymond Poincaré Garches

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of Goal Attainment Scaling (GAS). The percentage of patients who attain their Primary Treatment Goal determined using Goal Attainment Scaling (GAS) at each visits and in both groups. 6 months
Secondary Assessment of the Functional Independence Measure (FIM) 6 months
Secondary Assessment of Hemispatial neglect 6 months
Secondary Quality of life questionnaire 6 months
Secondary Assessment of slight deficits according MOCA scale (Montréal Cognitive Assessment) 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05436366 - Soleus Loading Response During Walking N/A
Completed NCT05546190 - A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
Completed NCT03549975 - Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study Phase 4
Active, not recruiting NCT06001736 - Utility of CC7 Transfer in Stroke Subtypes N/A
Completed NCT02969356 - Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC) Phase 4
Recruiting NCT03402854 - tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy N/A